Article
Immunological considerations for embryonic and induced pluripotent stem cell banking
4 Jul 2011
Abstract excerpt
Recent advances in stem cell technology have generated enthusiasm for their potential to study and treat a diverse range of human disease. Pluripotent human stem cells for therapeutic use may, in principle, be obtained from two sources: embryonic stem cells (hESCs), which are capable of extensive self-renewal and expansion and have the potential to differentiate into any somatic tissue, and induced pluripotent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
